CTRI/2023/04/051652尚未招募Unknown
Safety and Efficacy of Polymyxin B, Trimethoprim plus Rifampin for the Treatment of bacterial infectious Keratitis
V Prasad Eye Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects have given written informed consent to participate in the study
- •2.Subject has a clinical diagnosis of suspected bacterial keratitis in one eye only (study eye) defined as an ulceration of the epithelium characterized by fluorescein staining with focal or diffuse suppurative stromal inflammation, cellular infiltration in the adjacent stroma with or without anterior chamber cellular reaction
- •3.If subject is a female of childbearing potential, she must utilize a reliable contraceptive method [chemical contraceptive (oral, implantable, or injectable), spermicide with barrier, or IUD] throughout the study, and must have a negative urine pregnancy test prior to enrollment in this study
- •4.Subject is 18 years of age or older
- •5.Subject understands the scope of the study and is willing to follow instructions and able to make all required study visits
- •6.Subjects has best-corrected visual acuity (ETDRS) of +1.0 logMAR (Snellen equivalent 20/200) or better in the fellow eye
排除标准
- •1.Presence of suspected fungal, viral, or parasitic ocular infection in the study eye
- •2.Size of the ulcer <1mm or >6mm.
- •3.Presence of corneal thinning >50% or any signs of perforation or near perforation.
- •4.Females who are lactating, pregnant or are planning a pregnancy, or females of childbearing potential not using a reliable method of contraception
- •5.Contact lens wear in the study eye during study period
- •6.Use of any topical non-ocular or systemic antimicrobial (including subconjunctival injections) or steroid within 24 hours prior to enrollment into the study or during the study
- •7.Use of topical ocular antimicrobial or steroid solution in the study eye within 2 hours prior to enrollment into the study or during the study. Patient should not have been on other pre-study antimicrobial therapy for corneal ulcer for >24 hours
- •8.Subject with suspected bacterial endophthalmitis or bacterial scleritis.
- •9.Use of any systemic/topical investigational drug or device during the study or within 30 days before receipt of study medication. Patient cannot have previously been enrolled in this study
- •10.Ocular surgery in the study eye within six weeks before the beginning of the study
- •11.Cardiovascular or respiratory surgery within six weeks before the beginning of the study
- •12.History of allergy or sensitivity to polymyxins, trimethoprim, rifampins, or any component of the study medications, including the preservative BAK
- •13.Current alcohol and/or drug abuse
- •14.History of retinal detachment, diabetic retinopathy, or any retinal disease which may be progressive during the study
- •15.Any history of uncontrolled chronic systemic disease (e.g., cardiovascular disease, hypertension, or diabetes)
- •16.Any history of autoimmune disease that the investigator feels may interfere with the study parameters (e.g., acquired immune-deficiency syndrome or rheumatoid arthritis)
- •17.Any abnormality or presence of any significant illness that could interfere with the study
研究者
相似试验
招募中
不适用
Study of usage and outcomes of Polymyxin B in serious Bacterial Infections in Indian patientsCTRI/2018/03/012366Wockhardt Limited
进行中（未招募）
不适用
Study of usage and outcomes of Polymyxin B in serious bacterial infectioCTRI/2018/02/012183Wockhardt Limited
招募中
不适用
Effectiveness of polymyxin B on severe infections caused by multi-drug resistant Gram negative organismsSevere infections caused by multi-drug resistant Gram negative organismsJPRN-UMIN000002677Division of Infectious Diseases Therapeutics. Kobe university50
尚未招募
不适用
Incidence and risk factors of higher antibiotic resistant bacteria in ICU patientsCTRI/2022/11/047072Souvik Chaudhuri
Unknown
3 期
Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant PathogensTraumaResistant InfectionCritical IllnessNCT03159078University of Puerto Rico40